Jump to main content
Jump to site search
PLANNED MAINTENANCE Close the message box

Scheduled maintenance work on Wednesday 22nd May 2019 from 11:00 AM to 1:00 PM (GMT).

During this time our website performance may be temporarily affected. We apologise for any inconvenience this might cause and thank you for your patience.


Issue 2, 2012
Previous Article Next Article

Misfolded proteins in Alzheimer's disease and type II diabetes

Author affiliations

Abstract

This tutorial review presents descriptions of two amyloidogenic proteins, amyloid-β (Aβ) peptides and islet amyloid polypeptide (IAPP), whose misfolding propensities are implicated in Alzheimer's disease (AD) and type II diabetes, respectively. Protein misfolding diseases share similarities, as well as some unique protein-specific traits, that could contribute to the initiation and/or development of their associated conditions. Aβ and IAPP are representative amyloidoses and are used to highlight some of the primary considerations for studying misfolded proteins associated with human diseases in this review. Among these factors, their physiological formation, aggregation, interactions with metal ions and other protein partners, and toxicity are presented. Small molecules that target and modulate the metal–Aβ interaction and neurotoxicity are included to illustrate one of the current approaches for uncovering the complexities of protein misfolding at the molecular level.

Graphical abstract: Misfolded proteins in Alzheimer's disease and type II diabetes

Back to tab navigation

Publication details

The article was received on 23 Apr 2011 and first published on 04 Aug 2011


Article type: Tutorial Review
DOI: 10.1039/C1CS15112F
Chem. Soc. Rev., 2012,41, 608-621

  •   Request permissions

    Misfolded proteins in Alzheimer's disease and type II diabetes

    A. S. DeToma, S. Salamekh, A. Ramamoorthy and M. H. Lim, Chem. Soc. Rev., 2012, 41, 608
    DOI: 10.1039/C1CS15112F

Search articles by author

Spotlight

Advertisements